RHBDF2
protein-codingrhomboid 5 homolog 2, the group of Rhomboid family
Gene summary
Predicted to enable protein transporter activity. Predicted to be involved in several processes, including hair follicle morphogenesis; negative regulation of protein secretion; and regulation of signal transduction. Predicted to act upstream of or within protein localization to plasma membrane. Located in plasma membrane. Implicated in palmoplantar keratoderma-esophageal carcinoma syndrome. [provided by Alliance of Genome Resources, Jun 2026]
- RHBDL6
- TOC
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~30.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007856
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007856
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007856
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0007856
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007856
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007856
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007856
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0021094
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007856
Submitter: ClinGen
Tylosis esophageal cancer (TOC) is an autosomal-dominant (AD) syndrome characterized by palmoplantar keratoderma, oral precursor lesions, and a high lifetime risk of esophageal cancer. The gene-disease relationship of RHBDF2 and TOC was first reported by Blaydon et al. 2012(PMID: 22265016). Five unique missense variants in the RHBDF2 gene were reported to segregate with disease in 6 families, suggesting heterozygous gain of function is the mechanism of tumorigenesis for this gene. This gene-disease relationship is further supported by several mouse models and functional alteration studies. In summary, RHBDF2 is definitively associated with Tylosis esophageal cancer (TOC). This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Clinical Genomic Database (CGD)
Manifestation: Dermatologic; Gastrointestinal; Oncologic
Intervention: Oncologic
Rationale: Surveillance and early detection of and treatment for malignancy may decrease morbidity and mortality; Individuals may be at especially high risk of esophageal cancer with tobacco use
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RHBDF2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001005498.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | 75 | 2 | 87 | ||
| missense | 2 | 271 | 43 | 3 | 319 | |
| nonsense | 3 | 3 | ||||
| start loss | 0 | |||||
| frameshift | 4 | 4 | ||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 0 | 2 | 291 | 118 | 5 | 416 |
Highest pathogenic variant AF is 0.0000020665027
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001005498.2 | 17 | MANE Select | |
| Ensembl | ENSP00000501790.1 | 17 | MANE Select | |
| RefSeq | NP_001363157.1 | 17 | Standard | |
| RefSeq | NP_001363158.1 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- proteolysis
- protein transport
- regulation of epidermal growth factor receptor signaling pathway
- regulation of protein secretion
- negative regulation of protein secretion
Molecular Function
- serine-type endopeptidase activity
- growth factor binding
Cellular Component
- endoplasmic reticulum membrane
- plasma membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000313080
- Coding exons
- 17
- Length
- 30900
- Individuals with no LoFs
- 125714
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 32
- Defined
- 125746
- p
- 0.000127
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.79 | 432 | 550 | 0.785 | 0.0000371 | 5505 |
| Missense (PolyPhen) | 148 | 228.83 | 0.64676 | 2302 | ||
| Synonymous | 0.742 | 215 | 229 | 0.938 | 0.0000157 | 1674 |
| Loss of Function | 4.04 | 13 | 40.9 | 0.318 | 0.00000200 | 430 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.000072 | 0.000070 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Rhomboid protease-like protein which has no protease activity but regulates the secretion of several ligands of the epidermal growth factor receptor. Indirectly activates the epidermal growth factor receptor signaling pathway and may thereby regulate sleep, cell survival, proliferation and migration (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- LoFtool
- 0.756
- RVIS EVS
- -0.37
- RVIS percentile EVS
- 28.29
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.650
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |